Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
United Therapeutics Corporation to Report Third Quarter 2026 Financial Results Before Market Open on Wednesday, November 4, 2026
-
SS&C GlobeOp Forward Redemption Indicator: October Notifications 1.62%
-
Micron Biomedical Awarded Federal Vaccine Contract to Fight Rotavirus Through The Skin, Without Needles
-
GOWell Energy Technology Reports Operating Subsidiary’s First Half 2026 Financial Results and Provides Corporate Update
-
Altera’s 100G FPGA-Based Holoscan Sensor Bridge Solution on Display at NVIDIA GTC Berlin
-
Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
-
Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU)
-
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
-
Reborn Coffee Signs Master Product Supply Agreement with Visvita Corporation
-
Sotera Health Announces Third-Quarter 2026 Earnings Release Date
-
Old National Bancorp Reports Record Third Quarter 2026 Results
-
AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms
-
Agility Robotics Expands Pittsburgh Presence to Support Growing Customer Deployments
-
Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2026 Results
-
PyroGenesis Announces Dubai Subsidiary to Address Growing Opportunities in Middle East and Asian Markets
-
Aeluma Announces Primit Parikh as Strategic Advisor
-
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
-
West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
-
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
-
OTC Markets Group Names Meighan McGowan Executive Vice President, Corporate Services
-
Arteris to Announce Financial Results for the Third Quarter 2026 on Thursday, November 5, 2026
-
Human Feedback Foundation, with support from RBC, launches the Agentic AI Design Exchange to help Canadian nonprofits design their own AI agents
-
Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
-
Kaltura to Announce Financial Results for Third Quarter 2026 on Monday, November 9, 2026
-
Satellos to Participate in Upcoming Investor Conferences
-
Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
-
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
-
Notification of share transactions by Lumen Investments S.à r.l
-
Artea Bank Invitation to 9 months 2026 Financial Results Webinar
-
Sitryx to Participate in Upcoming Investor Conferences
-
Tastewise and NIQ Connect Consumer Demand with Trusted Retail Performance for Food and Beverage Brands
-
Philip Morris International Reports 2026 Third-Quarter & First Nine-Months Results and Updates 2026 Full-Year Adjusted Diluted EPS Forecast for Currency Only;
-
REGO Guardian Gives Platforms Verified Parental Consent Through a Single API
-
Teledyne Technologies Reports Third Quarter Results
-
Northern Trust Corporation Reports Third Quarter 2026 Financial Results
-
Funko to Announce 2026 Third Quarter Financial Results and Host Video Webcast on Thursday, November 5, 2026
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Labcorp Declares Quarterly Dividend
-
Compvide Announces Commercial Launch of CIMED and Presents New Research at European Meeting on Complement in Human Disease (EMCHD) 2026
-
BankUnited, Inc. Reports 3Q 2026 Net Income of $72 million, $1.01 Diluted EPS; Excluding Impact of Securities Sales, Net Income of $74 million, $1.03 Diluted EPS
-
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
-
Magna Mining Reports Results of Crean Hill Pre-Feasibility Study With Construction to Begin in 2027
-
JBT Marel Corporation Announces Third Quarter 2026 Earnings Release and Conference Call Schedule
-
MIAX Launches Physically-settled Fertilizer Futures on MIAX Futures
-
OneSpaWorld Announces Third Quarter Fiscal 2026 Financial Results on October 28, 2026
-
Options Expands Data Coverage with Nasdaq Options Feeds
-
Form 8.5 (EPT/RI)-Logistics Development Group plc
-
Injective Collaborates with BDACS to Bring Korea's First Won-Backed Stablecoin to Onchain RWAs
-
Injective Collaborates with BDACS to Bring Korea's First Won-Backed Stablecoin to Onchain RWAs
-
Form 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
